Swiss Paraplegic Research, Nottwil, Switzerland.
Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
Spinal Cord. 2023 Jan;61(1):43-50. doi: 10.1038/s41393-022-00860-4. Epub 2022 Oct 12.
Prospective, multicenter, longitudinal cohort study.
To describe female-male differences in first-line urological management during spinal cord injury (SCI) rehabilitation.
Inpatient specialized post-acute SCI rehabilitation in Switzerland.
Data on bladder storage medication (antimuscarinic and beta-3 agonist) use, suprapubic catheter placement, demographic and SCI characteristics was collected within 40 days of SCI and at rehabilitation discharge from May 2013-September 2021. Prevalence and indicators of bladder storage medication and suprapubic catheter use at discharge were investigated with sex-stratified descriptive and logistic regression analyses.
In 748 patients (219 females, 29%), bladder storage medication use at discharge had a prevalence of 24% (95% CI: 18-29%) for females and 30% (95% CI: 26-34%) for males and was indicated by cervical AIS grade A, B, C and traumatic SCI in both sexes. Thoracic AIS grade A, B, C SCI (males), and lumbar/sacral AIS grade A, B, C SCI (females) predicted higher odds of bladder storage medication use (SCI characteristicsex interaction, p < 0.01). Prevalence of suprapubic catheter use at discharge was 22% (95% CI: 17-28%) for females and 17% (95% CI: 14-20%) for males. Suprapubic catheter use was indicated by cervical AIS grade A, B, C SCI, and age >60 in both sexes. Females with thoracic grade A, B, C SCI tended to have higher odds of suprapubic catheter use (SCI characteristicsex interaction, p = 0.013).
We identified sex differences in urological management especially in persons with AIS grade C or higher sub-cervical SCI. There is scope for well-powered, female-specific research in SCI in order to understand the underlying mechanisms and support patient-tailored management.
前瞻性、多中心、纵向队列研究。
描述脊髓损伤 (SCI) 康复期间一线泌尿科管理中的男女差异。
瑞士住院后急性 SCI 康复。
在 2013 年 5 月至 2021 年 9 月期间,在 SCI 后 40 天内和康复出院时收集了关于膀胱储存药物(抗毒蕈碱和β-3 激动剂)使用、耻骨上导管放置、人口统计学和 SCI 特征的数据。使用性别分层描述性和逻辑回归分析调查出院时膀胱储存药物和耻骨上导管使用的流行率和指标。
在 748 名患者(219 名女性,29%)中,女性出院时使用膀胱储存药物的流行率为 24%(95%CI:18-29%),男性为 30%(95%CI:26-34%),并由颈椎 AIS 分级 A、B、C 和创伤性 SCI 预测。男女均预测膀胱储存药物使用的可能性更高:胸椎 AIS 分级 A、B、C SCI(男性)和腰椎/骶椎 AIS 分级 A、B、C SCI(女性)(SCI 特征性别交互作用,p < 0.01)。女性出院时耻骨上导管使用的流行率为 22%(95%CI:17-28%),男性为 17%(95%CI:14-20%)。男女均由颈椎 AIS 分级 A、B、C SCI 和年龄 >60 预测。女性胸椎 AIS 分级 A、B、C SCI 倾向于更高的耻骨上导管使用几率(SCI 特征性别交互作用,p = 0.013)。
我们在泌尿科管理方面发现了性别差异,尤其是在颈椎以下 AIS 分级 C 或更高的人群中。需要进行强有力的、针对女性的 SCI 特定研究,以了解潜在机制并支持针对患者的管理。